These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1033 related items for PubMed ID: 9422404

  • 1. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine.
    Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I.
    Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404
    [Abstract] [Full Text] [Related]

  • 2. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in pancreas transplantation.
    Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.
    Transplantation; 1998 Aug 15; 66(3):318-23. PubMed ID: 9721799
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.
    Transplantation; 1998 Dec 27; 66(12):1751-9. PubMed ID: 9884272
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants.
    Ciancio G, Miller J, Burke GW.
    Clin Transplant; 2001 Apr 27; 15(2):142-5. PubMed ID: 11264642
    [Abstract] [Full Text] [Related]

  • 10. Analysis of a single-center experience with mycophenolate mofetil based immunosuppression in renal transplantation.
    Triemer HL, Pearson TC, Odom KL, Larsen CP.
    Clin Transplant; 2000 Aug 27; 14(4 Pt 2):413-20. PubMed ID: 10946781
    [Abstract] [Full Text] [Related]

  • 11. Improved solitary pancreas transplant graft survival in the modern immunosuppressive era.
    Odorico JS, Becker YT, Groshek M, Werwinski C, Becker BN, Pirsch JD, Sollinger HW.
    Cell Transplant; 2000 Aug 27; 9(6):919-27. PubMed ID: 11202579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
    Stratta RJ, Alloway RR, Hodge E, Lo A, Pancreas Investigators Vital Outcomes Trial (PIVOT) Study Group.
    Clin Transplant; 2002 Feb 27; 16(1):60-8. PubMed ID: 11982617
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.
    Johnson C, Ahsan N, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, van Veldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.
    Transplantation; 2000 Mar 15; 69(5):834-41. PubMed ID: 10755536
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Thierry A, Le Meur Y, Ecotière L, Abou-Ayache R, Etienne I, Laurent C, Vuiblet V, Colosio C, Bouvier N, Aldigier JC, Rerolle JP, Javaugue V, Gand E, Bridoux F, Essig M, Hurault de Ligny B, Touchard G.
    Transpl Int; 2016 Jan 15; 29(1):23-33. PubMed ID: 26729582
    [Abstract] [Full Text] [Related]

  • 20. Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.
    Wüthrich RP, Weinreich T, Ambühl PM, Schwarzkopf AK, Candinas D, Binswanger U.
    Nephrol Dial Transplant; 1999 Feb 15; 14(2):394-9. PubMed ID: 10069195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.